THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 6.997.523 143.771 1
2017 0 8.875.332 248.038 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS GRONINGEN1
AMGEN1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
BAYER AKTIENGESELLSCHAFT1
BEITER GMBH GO KG1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CELGENE MANAGEMENT SARL1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONTIPRO AS1
CRITICAL PATH INSTITUTE STICHTING1
ELI LILLY AND COMPANY LIMITED1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN LABORATORY FOR NON LINEAR SPECTROSCOPY1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
F HOFFMANNLA ROCHE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FOLKEHELSEINSTITUTTET1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG EV1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
HEALTH IQ LIMITED1
HOCHSCHULE BIBERACH1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INTERSYSTEMS1
IQVIA SOLUTIONS BV1
JANSSEN PHARMACEUTICA NV1
JENSONR+ LIMITED1
KAROLINSKA INSTITUTE1
LGI CONSULTING1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MJR PHARMJET1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NOVAGO THERAPEUTICS1
NOVARTIS PHARMA1
NOVO NORDISK1
PFIZER LIMITED1
QUINTEN1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
SEMMELWEIS EGYETEM1
STATENS LEGEMIDDELVERK1
STICHTING DUTCH INSTITUTE FOR CLINICAL AUDITING1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
TANDVARDSOCH LAKEMEDELSFORMANSVERKET1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE UNIVERSITY OF LIVERPOOL1
TMF TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV1
UCB BIOPHARMA1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA COMMERCIALE LUIGI BOCCONI1
UNIVERSITAET BERN1
UNIVERSITE PARIS CITE1
UPPSALA UNIVERSITET1
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV1

Constancy:

Total number of partners: 59
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 59
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making More-EUROPAparticipant6.997.52314
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Nose to Brain Delivery of antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device N2B-patchparticipant5.325.49912